Denali Therapeutics Secures $130,000,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da9b96f4-9c07-4950-b959-b26fbc64d885 - Date
8/26/2016 - Company Name
Denali Therapeutics - Mailing Address
151 Oyster Point Blvd. South San Francisco, CA 94080 USA - Company Description
Denali is founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients. - Website
http://www.denalitherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$130,000,000 - Transaction Round
Series B - Proceeds Purposes
The company will use the funding to fund its drug candidate pipeline. - M&A Terms
- Venture Investor
Baillie Gifford - Venture Investor
Undisclosed
